$27.03 0.9%
WAY Stock Price vs. AI Score
Data gathered: October 6

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Waystar

Waystar Holding Corp. develops a cloud-based software solution for healthcare payments. Its platform offers financial clearance, patient financial care, claim and payment management, denial prevention and recovery, revenue capture, and analytics and reporting solutions.


Waystar
Price $27.03
Target Price Sign up
Volume 257,410
Market Cap $4.47B
Dividend Yield 0%
Analyst Rating 100% buy
Industry Health Care Services

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q2 '24235M80M154M-28M00.040
Q1 '24225M75M150M-16M0
Q4 '2300000
Q3 '2300000
Q2 '23196M61M135M-11M0

Insider Transactions View All

No recorded Insider transactions.

What is the Market Cap of Waystar?

The Market Cap of Waystar is $4.47B.

What is the current stock price of Waystar?

Currently, the price of one share of Waystar stock is $27.03.

How can I analyze the WAY stock price chart for investment decisions?

The WAY stock price chart above provides a comprehensive visual representation of Waystar's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Waystar shares. Our platform offers an up-to-date WAY stock price chart, along with technical data analysis and alternative data insights.

Does WAY offer dividends to its shareholders?

As of our latest update, Waystar (WAY) does not offer dividends to its shareholders. Investors interested in Waystar should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Waystar?

Some of the similar stocks of Waystar are Abbott Laboratories, HCA Healthcare, Cardinal Health, Henry Schein, and Idexx Laboratories.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.